Skip to content

Addiction: all studies

Page 329 of 863: studies 3,281 to 3,290 of 8,627, newest first. Back to the addiction overview

Research

Locus coeruleus co-activation patterns at rest show higher state persistence in patients with dissociative seizures: A Pilot Study.

Epilepsia open December 1, 2024 Samantha Weber, Johannes Jungilligens, Selma Aybek et al. 7 citations

Dissociative seizures are paroxysmal disruptions of awareness and behavioral control in the context of affective arousal. Alterations in stress-related endocrine function have been demonstrated, but the timescale of dissociation suggests that the central locus coeruleus (LC) noradrenergic system is likely pivotal. Here, we investigate whether LC activation at rest is associated with altered...

DOI: 10.1002/epi4.13050 (opens in new tab) Full text (opens in new tab) Co‐activation pattern Pnes Conversion disorder Coupling +4

Dissociative Trance Led to a Catastrophe: A Case Report.

Cureus December 1, 2024 Ahmed Z Salama, Mohammad R Dabash, Abdullah Elayan et al.

Dissociation is a cognitive process that disrupts consciousness, identity, or memory. It is frequently used as a form of defense in response to significant stress or trauma. In serious situations, it might show as a dissociative disorder, which extremely impairs psychological functioning. Dissociative trance, a type of other specified dissociative disorder (OSDD), is characterized by an abrupt...

DOI: 10.7759/cureus.76458 (opens in new tab) Full text (opens in new tab) Amnesia Cognitive behavioral therapy Dissociative trance Emotional stress +1

Relaxed Beliefs After Psychedelics: From Sensory Processing to Mystical States

December 1, 2024 Chloe Lily West Jacobs

This dissertation explores the lasting impact of psychedelic use on brain networks, ranging from basic sensory processing to abstract mystical experiences. Recent research has highlighted the potential of these substances for treating psychiatric disorders, with therapeutic effects persisting weeks after a single dose. We focus on serotonergic psychedelics such as psilocybin and LSD, which are...

DOI: 10.57709/tekc-cw79 (opens in new tab) Full text (opens in new tab) 5-MEO-DMT Psychedelics substances 5-ht2a psychedelics Brain network changes +8

Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.

Neuropsychopharmacology December 1, 2024 Charalampos Brakatselos, Alexia Polissidis, George Ntoulas et al. 10 citations

Repeated administration of ketamine (KET) has been used to model schizophrenia-like symptomatology in rodents, but the psychotomimetic neurobiological and neuroanatomical underpinnings remain elusive. In parallel, the unmet need for a better treatment of schizophrenia requires the development of novel therapeutic strategies. Cannabidiol (CBD), a major non-addictive phytocannabinoid has been...

DOI: 10.1038/s41386-024-01977-1 (opens in new tab) Full text (opens in new tab) CBD Schizophrenia treatment Brain research Psychiatric medicine

Abnormal resting-state functional connectivity of the right anterior cingulate cortex in chronic ketamine users and its correlation with cognitive impairments.

Asian Journal of Psychiatry December 1, 2024 Jun Zhong, Fengchun Wu, Huawang Wu et al. 1 citation

Chronic ketamine use leads to cognitive impairments, however, the neural mechanisms underpinning these impairments are still unclear. Many studies showed Anterior cingulate cortex (ACC)is strongly involved in cognition and drug addiction, as supported by our previous studies. The objective of this study was to assess the variations in resting-state functional connectivity (FC) changes in the...

DOI: 10.1016/j.ajp.2024.104199 (opens in new tab) Full text (opens in new tab) Chronic ketamine use Cognitive impairments Functional connectivity Brain connectivity +3

Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder.

CNS Drugs December 1, 2024 Ruyun Liu, Ning Liu, Lin Ma et al. 5 citations

Major depressive disorder (MDD) is a severe mental illness with a complex etiology. Currently, many medications employed in clinical treatment exhibit limitations such as delayed onset of action and a high incidence of adverse reactions. Therefore, there is a pressing need to develop antidepressants that exhibit enhanced efficacy and safety. The N-methyl-D-aspartate receptor (NMDAR), a...

DOI: 10.1007/s40263-024-01123-x (opens in new tab) Full text (opens in new tab) Mental-health Depression-treatment Drug-development Brain-research

General Anesthesia Occludes Ketamine's Antidepressant Response in a Rodent Model of Chronic Stress.

Psychedelic Medicine December 1, 2024 Daniel Markman, Andrzej Z Wasilczuk, Joseph Michael Cichon 2 citations

Psychedelic-induced experiences are thought to play an important role in the therapeutic actions of rapid-acting antidepressants. General anesthesia is one scenario in which patients can be rendered unconscious and masked to the psychedelic treatment, providing a simple yet effective method to examine drug-induced changes in the brain devoid of experiences. Chronically stressed adult C57/BL6...

DOI: 10.1089/psymed.2024.0007 (opens in new tab) Full text (opens in new tab) Antidepressant response Chronic stress Dissociation General anesthesia +6

Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.

Journal of the American Academy of Child & Adolescent Psychiatry December 1, 2024 Jessica K Jeffrey, Marc J. Weintraub, Charles S. Grob 12 citations

Youth today are burdened by significant mental health challenges. In 2022, 25% of adolescents aged 12 to 17 years experienced a mental illness, with 20% experiencing a depressive episode, 12.5% reporting serious thoughts of suicide, and 17% meeting criteria for a substance use disorder.1 Close to 5% of adolescents experience posttraumatic stress disorder.2 Impairing psychiatric symptoms remain...

Exploring the regulatory framework of psychedelics in the US & Europe.

Asian Journal of Psychiatry December 1, 2024 Hitesh Kumar Behera, Ramesh Joga, Sravani Yerram et al.

Psychedelic drug therapy has gained prominence for its potential in treating various mental health conditions, including depression, post-traumatic stress disorder (PTSD), and anxiety. Psychedelic treatment differs from conventional psychiatric approaches in mode of action, legal status, and treatment approach. This work delves into the therapeutic potential, mechanisms, and regulatory...

Traditional Indigenous-Amazonian Therapy Involving Ceremonial Tobacco Drinking as Medicine: A Transdisciplinary Multi-Epistemic Observational Study.

Health Education & Behavior December 1, 2024 Ilana Berlowitz, Ernesto García Torres, Juan Celidonio Ruiz Macedo et al. 3 citations

Although the tobacco plant has been employed as a medicinal and sacred herb by Indigenous cultures across the Americas, its usage drastically changed after the 15th-century colonial arrival; its large-scale commodification and global marketing once brought to Europe lead to hedonic and addictive uses harmful to health. As a consequence, tobacco smoking is now one of the largest public health...

DOI: 10.1177/10901981231213348 (opens in new tab) Full text (opens in new tab) Ayahuasca Mental health therapy Indigenous healing practices Medicinal tobacco +6